𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage

Book ID
123023599
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
142 KB
Volume
14
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Alterations of CDKN2 (p16) in non-small
Alterations of CDKN2 (p16) in non-small cell lung cancer
✍ Sven De Vos; Carl W. Miller; Seisho Takeuchi; Adrian F. Gombart; Steve K. Cho; H πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 567 KB

## Abstract The cyclin‐dependent kinase inhibitor known as __p16__ (__CDK41, CDKN2, INK4A, MTS1__) has been proposed as a tumor suppressor gene on chromosome segment 9p21. We have evaluated __CDKN2__ alterations in 34 non‐small cell lung cancers (NSCLCs) with matched normal tissue controls and in 9

Inactivation of p16/CDKN2 and p15/MTS2 i
Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer
✍ Kazuya Kudoh; Yoshihito Ichikawa; Sadao Yoshida; Misako Hirai; Yoshihiro Kikuchi πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 130 KB

## Abstract To define the involvement of __p16/CDKN2__ and __p15/MTS2__ tumor‐suppressor genes for response to chemotherapy in primary epithelial ovarian cancer, we analyzed alterations of the gene in 45 patients who were treated with primary cytoreductive surgery followed by 6 courses of cis‐diamm